1|0|Public
50|$|<b>Omiloxetine</b> (omiloextinum, omiloxetino INN) was a {{selective}} serotonin reuptake inhibitor drug candidate that underwent preclinical development by the Spanish pharmaceutical company, Ferrer Internacional, until 2005, {{when it was}} abandoned.|$|E

